Article
Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors.
Future oncology (London, England) - 1 Jan 2015
Moschini Ilaria, Dell'Anna Cristina, Losardo Pier Luigi, Bordi Paola, D'Abbiero Nunziata, Tiseo Marcello
Abstract excerpt
Non-small-cell lung cancer (NSCLC) occurs, approximately, in 80-85% of all cases of lung cancer. The majority of patients present locally advanced or metastatic disease when diagnosed, with poor prognosis. The discovery of activating mutations in the EGFR gene has started a new era of personalized treatment for NSCLC patients. To improve the treatment outcome in patients with unresectable NSCLC and, in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.